Literature DB >> 30801736

Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants.

Ravi Mangal Patel1, Andrea Knezevic2,3, Jing Yang2,4, Neeta Shenvi2, Michael Hinkes5, John D Roback6, Kirk A Easley2, Cassandra D Josephson6,7.   

Abstract

BACKGROUND: Enteral iron supplementation and RBC transfusions are routinely administered to very-low-birth-weight (VLBW) infants, although the potential risks of these exposures have not been adequately quantified. This study evaluated the association between the cumulative dose of enteral iron supplementation, total volume of RBCs transfused, and risk of bronchopulmonary dysplasia (BPD) in VLBW infants. STUDY DESIGN AND METHODS: Retrospective, multicenter observational cohort study in Atlanta, Georgia. Cumulative supplemental enteral iron exposure and total volume of RBCs transfused were measured until the age at assessment of BPD. Multivariable generalized linear models were used to control for confounding, and the reliability of the factors was assessed in 1000 bootstrap models.
RESULTS: A total of 598 VLBW infants were studied. In multivariable analyses, a greater cumulative dose of supplemental enteral iron exposure was associated with an increased risk of BPD (adjusted relative risk per 50-mg increase, 1.07; 95% confidence interval [CI], 1.02-1.11; p = 0.002). Similarly, a greater volume of RBCs transfused was associated with a higher risk of BPD (adjusted relative risk per 20-mL increase, 1.05; 95% CI, 1.02-1.07; p < 0.001). Both factors were reliably associated with BPD (>50%). Volume of RBCs transfused was similar to gestational age in reliability as a risk factor for BPD (present in 100% of models) and was more reliable than mechanical ventilation at 1 week of age.
CONCLUSION: The cumulative dose of supplemental enteral iron exposure and total volume of RBC transfusion are both independently associated with an increased risk of BPD in VLBW infants.
© 2019 AABB.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30801736      PMCID: PMC6499698          DOI: 10.1111/trf.15216

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  33 in total

1.  Akaike's information criterion in generalized estimating equations.

Authors:  W Pan
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

3.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

4.  Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants.

Authors:  K Hirano; T Morinobu; H Kim; M Hiroi; R Ban; S Ogawa; H Ogihara; H Tamai; T Ogihara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

5.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

6.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  BMJ       Date:  2007-10-20

7.  Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants.

Authors:  Susan M Miller; Ronald J McPherson; Sandra E Juul
Journal:  J Pediatr       Date:  2006-01       Impact factor: 4.406

8.  Impact of a physiologic definition on bronchopulmonary dysplasia rates.

Authors:  Michele C Walsh; Qing Yao; Patricia Gettner; Ellen Hale; Monica Collins; Angelita Hensman; Ruth Everette; Nancy Peters; Nancy Miller; Gerry Muran; Kathy Auten; Nancy Newman; Gina Rowan; Cathy Grisby; Kathy Arnell; Lucy Miller; Bethany Ball; Georgia McDavid
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

9.  Is there a causal relationship between the receipt of blood transfusions and the development of chronic lung disease of prematurity?

Authors:  Keith J Collard
Journal:  Med Hypotheses       Date:  2005-10-19       Impact factor: 1.538

10.  Oxidative stress markers and antioxidant status after oral iron supplementation to very low birth weight infants.

Authors:  Kristin Braekke; Anne Grete Bechensteen; Bente Lise Halvorsen; Rune Blomhoff; Kirsti Haaland; Anne Cathrine Staff
Journal:  J Pediatr       Date:  2007-07       Impact factor: 4.406

View more
  5 in total

Review 1.  Nutritional Supplements to Improve Outcomes in Preterm Neonates.

Authors:  Mohan Pammi; Ravi M Patel
Journal:  Clin Perinatol       Date:  2022-04-21       Impact factor: 2.642

Review 2.  Transfusion in Neonatal Patients: Review of Evidence-Based Guidelines.

Authors:  Patricia E Zerra; Cassandra D Josephson
Journal:  Clin Lab Med       Date:  2020-12-23       Impact factor: 2.172

Review 3.  Iron Homeostasis Disruption and Oxidative Stress in Preterm Newborns.

Authors:  Genny Raffaeli; Francesca Manzoni; Valeria Cortesi; Giacomo Cavallaro; Fabio Mosca; Stefano Ghirardello
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

4.  Red blood cell transfusions post diagnosis of necrotizing enterocolitis and the deterioration of necrotizing enterocolitis in full-term and near-term infants: a propensity score adjustment retrospective cohort study.

Authors:  Lijuan Luo; Xingling Liu; Huan Yu; Mei Luo; Wen Jia; Wenbin Dong; Xiaoping Lei
Journal:  BMC Pediatr       Date:  2022-04-15       Impact factor: 2.567

5.  Association of Blood Donor Sex and Age With Outcomes in Very Low-Birth-Weight Infants Receiving Blood Transfusion.

Authors:  Ravi M Patel; Joshua Lukemire; Neeta Shenvi; Connie Arthur; Sean R Stowell; Martha Sola-Visner; Kirk Easley; John D Roback; Ying Guo; Cassandra D Josephson
Journal:  JAMA Netw Open       Date:  2021-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.